Back to Browse Journals » Clinical Pharmacology: Advances and Applications » Volume 2

Nanoparticle-labeled stem cells: a novel therapeutic vehicle

Authors Abir O El-Sadik, Afaf El-Ansary, Sherif M Sabry

Published Date March 2010 Volume 2010:2 Pages 9—16


Published 16 March 2010

Abir O El-Sadik1, Afaf El-Ansary2, Sherif M Sabry3

1Stem Cell Unit, Anatomy Department, College of Medicine, Health Science Colleges; 2Biochemistry Department, Science College, King Saud University; 3Anatomy Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Abstract: Nanotechnology has been described as a general purpose technology. It has already generated a range of inventions and innovations. Development of nanotechnology will provide clinical medicine with a range of new diagnostic and therapeutic opportunities such as medical imaging, medical diagnosis, drug delivery, and cancer detection and management. Nanoparticles such as manganese, polystyrene, silica, titanium oxide, gold, silver, carbon, quantum dots, and iron oxide have received enormous attention in the creation of new types of analytical tools for biotechnology and life sciences. Labeling of stem cells with nanoparticles overcame the problems in homing and fixing stem cells to their desired site and guiding extension of stem cells to specific directions. Although the biologic effects of some nanoparticles have already been assessed, information on toxicity and possible mechanisms of various particle types remains inadequate. The aim of this review is to give an overview of the mechanisms of internalization and distribution of nanoparticles inside stem cells, as well as the influence of different types of nanoparticles on stem cell viability, proliferation, differentiation, and cytotoxicity, and to assess the role of nanoparticles in tracking the fate of stem cells used in tissue regeneration.
Keywords: nanoparticles, stem cells, uptake, differentiation, cytotoxicity, tracking

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Potential sources of stem cells as a regenerative therapy for Parkinson's disease

Abir Oueida El-Sadik

Stem Cells and Cloning: Advances and Applications 2010, 3:183-191

Published Date: 6 December 2010

Readers of this article also read:

Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity

Zhao QQ, Hu YL, Zhou Y, Li N, Han M, Tang GP, Qiu F, Tabata Y, Gao JQ

International Journal of Nanomedicine 2012, 7:3191-3202

Published Date: 27 June 2012

Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG

Clinical Ophthalmology 2012, 6:343-363

Published Date: 6 March 2012

Celecoxib does not significantly delay bone healing in a rat femoral osteotomy model: a bone histomorphometry study

Iwamoto J, Seki A, Sato Y, Matsumoto H

Orthopedic Research and Reviews 2011, 3:39-45

Published Date: 9 December 2011

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

Stricker RB, DeLong AK, Green CL, Savely VR, Chamallas SN, Johnson L

International Journal of General Medicine 2011, 4:639-646

Published Date: 6 September 2011

Amino acid management of Parkinson’s disease: a case study

Marty Hinz, Alvin Stein, Thomas Uncini

International Journal of General Medicine 2011, 4:165-174

Published Date: 28 February 2011

Computer simulation of a novel pharmaceutical silicon nanocarrier

Saeed Soltani, Soroush Sardar, Sima Azadi Soror

Nanotechnology, Science and Applications 2010, 3:149-157

Published Date: 16 November 2010

Neurotransmitter testing of the urine: a comprehensive analysis

Marty Hinz, Alvin Stein, George Trachte, et al

Research and Reports in Urology 2010, 2:177-183

Published Date: 7 October 2010

Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

Evelina Miele, Gian Paolo Spinelli, Ermanno Miele, Federica Tomao, Silverio Tomao

International Journal of Nanomedicine 2009, 4:99-105

Published Date: 27 April 2009

Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency

Sadhana V Kulkarni, Karim F Damji, Yvonne M Buys

Patient Preference and Adherence 2008, 2:303-313

Published Date: 18 November 2008